Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Vir Biotechnology in the transaction. Vir Biotechnology (Nasdaq: VIR) announced it has entered into an exclusive worldwide license agreement with Sanofi for...
You must be a Standard 1 Year member to access this content.
Arnold & Porter Kaye Scholer advised Pharmacosmos, while Ropes & Gray and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented G1 Therapeutics on the deal....
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Skydance and the Investor Group on the transaction; Sullivan & Cromwell advised RedBird Capital Partners; Ropes & Gray advised National Amusements; Cravath,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Altamont Capital Partners in the transaction. Sony Pictures Entertainment (SPE) and Alamo Drafthouse Cinema (Alamo Drafthouse) announced that SPE has acquired Alamo...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett is representing Frontdoor, Inc. in the transaction, and Ropes & Gray is representing Genstar Capital. Frontdoor, Inc. (NASDAQ: FTDR), the nation’s leading...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Novavax Inc. in the transaction. Novavax Inc.(Nasdaq: NVAX) announced it has entered into a co-exclusive licensing agreement with French pharmaceutical company Sanofi...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Provention Bio, Inc. on the deal. Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced a sales agreement...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented HUTCHMED on the deal. HUTCHMED (China) Limited and its subsidiary, HUTCHMED Limited announced an exclusive worldwide license agreement with Japan’s largest drugmaker Takeda...
You must be a Standard 1 Year member to access this content.
